Louisiana Board of Pharmacy to consider a number of Rule Changes including reinstating a provision that reinstated provision to office use for veterinarians only, since the recent federal compounding law prohibits pharmacies from compounding human drugs for office use; other rules such as telepharmacy service to be considered

Regulatory Proposals

2015-H ~ Amends Chapter 15 - Hospital Pharmacy to a new Section §1527 ~ Remote Access to Medical Orders.  This rule will permit a pharmacist employed by or under contract with a hospital pharmacy to have access to that pharmacy's dispensing information system from a location other than a pharmacy in order to process prescription drug orders or medical orders, but only under certain circumstances.
               04-30-2015 - Committee reviewed Draft #1 and then voted to recommend its approval at the next Board meeting.
               05-27-2015 - Draft #1 scheduled for consideration by the Board.


2015-G ~ Amends Chaptaer 24 ~ Limited Service Providers by creating a new Subchapter D ~ Remote Processor Pharmacy.  This rule will develop a new type of pharmacy permit for a remote processor pharmacy that may be established within the state.  This type of pharmacy will not be permitted to procure, possess, or dispense any prescription drugs or controlled substances, but will be permitted to perform remote processing services for other pharmacies.
               04-30-2015 - Committee reviewed Draft #1, requested one amendment, then voted to recommend the approval of Draft #2 at the next Board meeting.
               05-27-2015 - Draft #2 scheduled for consideration by the Board.


2015-F ~ Amends Chapter 24 ~ Limited Service Providers by creating a new Subchapter C ~ Telepharmacy Services.  This rule will develop a new type of pharmacy permit for a telepharmcy dispensing site to be placed in an area without pharmacy services that can be supervised via technology by another pharmacy within the state.
               04-30-2015 - Committee reviewed Draft #1 and requested several amendments.
               05-26-2015 - Committee scheduled to review Draft #2; if approved, will recommend it to the full Board during their meeting the following day.


2015-E ~ Amends Chapter 25 - Prescriptions, Drugs, & Devices, more specifically §2511 - Prescriptions, to reinstate, for a temporary amount of time, the recognition of an electronic signature of the prescriber on a prescription for a drug not listed as a controlled substance that is received by facsimile in a pharmacy.
               04-29-2015 - Committee reviewed Draft #1 and requested one amendment, then voted to recommend the approval of Draft #2 at the next Board meeting.
               05-27-2015 - Draft #2 scheduled for consideration by the Board.             


2015-D ~ Amends Chapter 25 - Prescriptions, Drugs, & Devices, more specifically §2535 - General Compounding Standards, to reinstate a provision that would enable pharmacies to compound medications for office use (sometimes known as compounding for practitioner administration, or pharmacy-generated drugs).  The proposal seeks to limit the reinstated provision to office use for veterinarians only, since the recent federal compounding law prohibits pharmacies from compounding human drugs for office use.
               04-29-2015 - Committee reviewed Draft #1 and requested two amendments, then voted to recommend the approval of Draft #2 at the next Board meeting.
               05-27-2015 - Draft #2 scheduled for consideration by the Board.